Is drug‐eluting bead transcatheter arterial chemoembolization (TACE) associated with better tumor response than conventional TACE in meta‐analysis?

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|12|1258-1259

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.12, 2015-12, pp. : 1258-1259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is drug‐eluting‐bead transcatheter arterial chemoembolization (TACE) associated with better tumor response than conventional TACE in a meta‐analysis?: Authors’ reply

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 12, 2015-12 ,pp. : 1260-1261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma

By  

Oncology, Vol. 80, Iss. 3-4, 2011-06 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

Transcatheter arterial chemoembolization (TACE) for lymph node metastases in patients with hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 4, 2015-08 ,pp. : 372-376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transcatheter arterial chemoembolization (TACE) for lymph node metastases in patients with hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 22-4790, Iss. 4, 2015-08 ,pp. : 372-376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

By Sato Yozo  

Upsala Journal of Medical Sciences, Vol. 118, Iss. 1, 2013-03 ,pp. : 16-22

Informa Healthcare

Access to resources Recommend Favorite